Publications by authors named "Bengt Rasmussen"

Claim this Profile
I
Influence of Cytogenetics on the Outcome of Patients With High-Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without Lenalidomide.
Bengt Rasmussen, Lars Nilsson, Magnus Tobiasson, Martin Jädersten, Hege Garelius

Genes Chromosomes Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes.
Maria Creignou, Elsa Bernard, Alessandro Gasparini, Anna Tranberg, Gabriele Todisco, Bengt Rasmussen

J Intern Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.
Magnus Tobiasson, Tatjana Pandzic, Johanna Illman, Lars Nilsson, Simone Weström, Bengt Rasmussen

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients.
Gunnar Larfors, Daniel Moreno Berggren, Hege Garelius, Lars Nilsson, Bengt Rasmussen

Leuk Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related MDS dissected based on primary disease and treatment-a nationwide perspective.
Daniel Moreno Berggren, Hege Garelius, Petter Willner Hjelm, Lars Nilsson, Bengt Rasmussen

Leukemia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)".
Bengt Rasmussen, Gudrun Göhring, Elsa Bernard, Lars Nilsson, Magnus Tobiasson

Leukemia· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Income, education and their impact on treatments and survival in patients with myelodysplastic syndromes.
Gunnar Larfors, Daniel Moreno Berggren, Hege Garelius, Martin Jädersten, Lars Nilsson, Bengt Rasmussen

Eur J Haematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study.
Daniel Moreno Berggren, Matilda Kjellander, Ellen Backlund, Marie Engvall, Hege Garelius, Bengt Rasmussen

Br J Haematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register.
Daniel Moreno Berggren, Yasin Folkvaljon, Marie Engvall, Johan Sundberg, Mats Lambe, Bengt Rasmussen

Br J Haematol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis